Thus, the primary causative factor responsible for such an expression profile in AD clinical cases remains yet to be identified, but it is worth noting that both tau and Aβ-related pathologies can individually affect the endolysosomal system in similar ways. The gene discussed is MAPT; the disease is Alzheimer disease.